These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2673804)

  • 1. Current stage of interleukin 2 receptor targeted therapy.
    Diamantstein T; Kupiec-Weglinski JW; Strom TB; Tilney NL
    Exp Clin Endocrinol; 1989 May; 93(2-3):114-24. PubMed ID: 2673804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 receptor-targeted immune therapy.
    Diamantstein T; Hahn HJ
    Immunol Ser; 1993; 59():295-318. PubMed ID: 8461395
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A.
    Diamantstein T; Mouzaki A; Osawa H; Volk HD; Hahn HJ; Kirkman RL; Strom TB; Tilney NL; Kupiec-Weglinski JW
    Dev Biol Stand; 1988; 69():177-84. PubMed ID: 3066671
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current aspects in organ transplantation].
    Ryffel B
    Schweiz Rundsch Med Prax; 1989 Sep; 78(37):997-1002. PubMed ID: 2678372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anti-interleukin-2 receptor antibody treatment on recurrent autoimmune insulitis in the BB rat.
    Woehrle M; Pullmann J; Stuenkel KG; Bretzel RG; Federlin K
    Transplant Proc; 1994 Apr; 26(2):734-5. PubMed ID: 8171631
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal antibodies in human organ transplantation and auto-immune diseases.
    Wijdenes J; Roy C; Morel-Fourrier B; Racadot E
    Therapie; 1992; 47(4):283-7. PubMed ID: 1494788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of anti-interleukin-2 receptor alpha antibody in vivo induces localized autoimmune disease.
    Taguchi O; Takahashi T
    Eur J Immunol; 1996 Jul; 26(7):1608-12. PubMed ID: 8766568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation tolerance with monoclonal antibodies.
    Wood KJ
    Semin Immunol; 1990 Nov; 2(6):389-99. PubMed ID: 2104277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of temporary IL-2 receptor MAB therapy on islet allograft in autoimmune diabetes.
    Hahn HJ; Kuttler B; Lucke S; Dunger A; Besch W; Volk HD; Diamankstein T
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2711-3. PubMed ID: 2495678
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Towpik E; Lord RH; Ma L; Diamantstein T; Strom TB; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):591-3. PubMed ID: 2978926
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease.
    Bach JF
    C R Biol; 2006 Apr; 329(4):260-2. PubMed ID: 16644496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.
    Junghans RP; Waldmann TA; Landolfi NF; Avdalovic NM; Schneider WP; Queen C
    Cancer Res; 1990 Mar; 50(5):1495-502. PubMed ID: 2406013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts.
    Waldmann TA; Goldman CK
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):45-53. PubMed ID: 2683757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis.
    Dejica D; Treichel U; Pár A; Chira O; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1997 Jan; 35(1):15-21. PubMed ID: 9123953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-cytokines and anti-cytokine receptors].
    Dantal J; Giral M; Soulillou JP
    Rev Prat; 1993 Mar; 43(5):586-9. PubMed ID: 8341928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats.
    Kuttler B; Kauert C; Wanka H; Diamantstein T; Hahn HJ
    J Autoimmun; 1996 Jun; 9(3):321-9. PubMed ID: 8816967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Targeted immunotherapy against interleukin 2 receptors (IL-2R)--an attempt at synthesis].
    Sabliński T; Wasik MA; Tilney NL; Kupiec-Wegliński JW
    Postepy Hig Med Dosw; 1992; 46(3):275-85. PubMed ID: 1293580
    [No Abstract]   [Full Text] [Related]  

  • 19. Interleukin receptors in lymphoid lesions. Relevance to diagnosis, biology, and therapy.
    Strauchen JA
    Pathol Annu; 1989; 24 Pt 2():149-65. PubMed ID: 2671880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 receptor antibody reduces rejection rates and graft loss in live-donor kidney transplant recipients.
    Lim WH; Chang SH; Chadban SJ; Campbell SB; Dent H; Russ GR; McDonald SP
    Transplantation; 2009 Nov; 88(10):1208-13. PubMed ID: 19935375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.